Rep. Thomas H. Kean, Jr. sold Johnson & Johnson (JNJ)
Rep. Thomas H. Kean, Jr. (R-NJ-7) · $15K–$50K · traded Jul 31, 2025
Why this is a committee overlap
Kean is a member of the House Committee on Energy and Commerce, which oversees the Healthcare sector. Johnson & Johnson is classified in the Drug Manufacturers - General industry.
An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.
- Transaction
- Sold (partial)
- Amount
- $15K–$50K
- Owner
- Not stated
- Traded
- Jul 31, 2025
- Disclosed
- Aug 20, 2025
- Days to disclose
- 20
- Asset type
- Stock
- As filed
- Johnson & Johnson Common Stock
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Aug 20, 2025$15K–$50K
$15K–$50K · Traded Jul 31, 2025 · disclosed Aug 20, 2025
Committee overlap: Energy and Commerce - Aug 20, 2025$15K–$50K
Bought Check Point Software Technologies CHKP
$15K–$50K · Traded Jul 29, 2025 · disclosed Aug 20, 2025
- Aug 20, 2025$1K–$15K
$1K–$15K · Traded Jul 29, 2025 · disclosed Aug 20, 2025
- Aug 20, 2025$1K–$15K
Bought Abbott Laboratories ABT
$1K–$15K · Traded Jul 21, 2025 · disclosed Aug 20, 2025
Committee overlap: Energy and Commerce - Aug 20, 2025$1K–$15K
Exchanged Liberty Broadband LBRDK
$1K–$15K · Traded Jul 15, 2025 · disclosed Aug 20, 2025 · Spouse
Committee overlap: Energy and Commerce
Recent Congress trades in JNJ
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and CommerceTraded 13 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 5, 2026$1K–$15K
Rep. Lloyd Doggett (D-TX-37)
$1K–$15K · Traded Sep 8, 2026 · disclosed Oct 5, 2026
- Sep 12, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Aug 27, 2026 · disclosed Sep 12, 2026
Committee overlap: Energy and Commerce - Sep 11, 2026$1K–$15K
Sen. John Boozman (R-AR)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 11, 2026 · Joint
- Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 30, 2026 · disclosed Jul 21, 2026 · filed 113 days later
Committee overlap: HELP
Company context for JNJ
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
JNJ: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.
2 congressional households disclosed purchases in the past 90 days. See the trades
JNJ: third_quarter 2026 lobbying report
Issues related to the 340B Drug Pricing Program. Issues related to the 340B Drug Pricing Program.
Public: Oct 20, 2026, 12:00 AM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
JNJ: third_quarter 2026 lobbying report
HR 6549, VA Contracting and Procurement Act PBM Medical Supply Chain program reforms, MSPV, PSAS, IT HR 9237, Taking Care of Veterans Act S2918, Veterans Prosthetics Advancement and Reform Act
Public: Oct 16, 2026, 12:14 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.